Yu‐Long Xie

Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma

Rui You, You‐Ping Liu, Pei‐Yu Huang et al. · JAMA Oncology · 2020 · 248 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Rui You, You‐Ping Liu, Yu‐Long Xie et al. · The Lancet · 2023 · 104 citations

Medicine, Oncology, Radiation Oncology +16

Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study

Xi Ding, Weijing Zhang, Rui You et al. · Journal of Clinical Oncology · 2023 · 70 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance

Lin Mei, Xiao-Long Zhang, Rui You et al. · Nature Communications · 2023 · 65 citations · Full text

Medicine, Evolutionary Biology, Oncology +17

Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial

Yi‐Jun Hua, Rui You, Zhiqiang Wang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 40 citations · Full text

Medicine, Oncology, Radiation Oncology +14